Data Providers · HealthVerity
analyzed GLP-1 persistence and adherence over two years across ~3.9M semaglutide patients
The customer is anonymised in HealthVerity’s own case study — not withheld by us.
HealthVerity is a real-world-data marketplace aggregating claims, EHR and lab data from 75+ sources via a proprietary patient-matching layer.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Source
Published by HealthVerity on its own site — read the original case study on info.healthverity.com ↗
More like this
Related use cases
- 01partnered to improve rare-disease campaign targeting using Symphony Health custom audience data and an Audience Quality Index
- 02used RWE to sharpen launch strategy and prescriber/patient targeting for an oral TYK2 inhibitor in psoriasis
- 03achieved 26.9x targeting precision in a rare kidney disease campaign via HealthVerity Audiences
- 04supplemented claims with oncology lab results to narrow 75,395 metastatic breast cancer patients to 1,188 subtype-confirmed patients
- 05used deeper clinical context via HealthVerity Audiences to more precisely target chronic liver disease patients for a specialty therapy
- 06used observed clinical signals instead of modeled assumptions to reach a rare hematologic disease patient population